CEACAM6 gene expression in intrahepatic cholangiocarcinoma

[1]  T. Utsunomiya,et al.  Characterization of a Side Population of Cancer Cells from Human Gastrointestinal System , 2006, Stem cells.

[2]  D. Goldenberg,et al.  Inhibition of adhesion, invasion, and metastasis by antibodies targeting CEACAM6 (NCA-90) and CEACAM5 (Carcinoembryonic Antigen). , 2005, Cancer research.

[3]  G. Gores,et al.  Erratum: Cholangiocarcinoma (Gastroenterology (2005) 128 (1655-1667)) , 2005 .

[4]  S. Thongprasert,et al.  The role of chemotherapy in cholangiocarcinoma. , 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

[5]  T. Utsunomiya,et al.  Clinical Significance of Human Kallikrein Gene 6 Messenger RNA Expression in Colorectal Cancer , 2005, Clinical Cancer Research.

[6]  S. Ashley,et al.  CEACAM6 Is a Novel Biomarker in Pancreatic Adenocarcinoma and PanIN Lesions , 2005, Annals of surgery.

[7]  S. Ashley,et al.  Systemic siRNA-Mediated Gene Silencing: A New Approach to Targeted Therapy of Cancer , 2004, Annals of surgery.

[8]  M. Bloomston,et al.  Cholangiocarcinoma: Advocate an Aggressive Operative Approach with Adjuvant Chemotherapy , 2004, The American surgeon.

[9]  H. Ito,et al.  CEACAM6 is a determinant of pancreatic adenocarcinoma cellular invasiveness , 2004, British Journal of Cancer.

[10]  S. Ashley,et al.  Overexpression of CEACAM6 promotes insulin-like growth factor I-induced pancreatic adenocarcinoma cellular invasiveness , 2004, Oncogene.

[11]  S. Ashley,et al.  A Novel Role for Carcinoembryonic Antigen-Related Cell Adhesion Molecule 6 as a Determinant of Gemcitabine Chemoresistance in Pancreatic Adenocarcinoma Cells , 2004, Cancer Research.

[12]  M. Olnes,et al.  A Review and Update on Cholangiocarcinoma , 2004, Oncology.

[13]  Hirofumi Nakayama,et al.  Search for new biomarkers of gastric cancer through serial analysis of gene expression and its clinical implications , 2004, Cancer science.

[14]  H. El‐Serag,et al.  The epidemiology of cholangiocarcinoma. , 2004, Seminars in liver disease.

[15]  S. Ashley,et al.  CEACAM6 gene silencing impairs anoikis resistance and in vivo metastatic ability of pancreatic adenocarcinoma cells , 2004, Oncogene.

[16]  R. Herrmann,et al.  Expression of CEACAM6 in resectable colorectal cancer: a factor of independent prognostic significance. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  H. Thomas,et al.  Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document , 2002, Gut.

[18]  C. Stanners,et al.  Deregulated expression of the human tumor marker CEA and CEA family member CEACAM6 disrupts tissue architecture and blocks colonocyte differentiation. , 2002, Neoplasia.

[19]  Keizo Sugimachi,et al.  Analysis of the gene-expression profile regarding the progression of human gastric carcinoma. , 2002, Surgery.

[20]  C. Stanners,et al.  Human carcinoembryonic antigen functions as a general inhibitor of anoikis. , 2000, Cancer research.

[21]  S Jothy,et al.  Apoptosis, anoikis and their relevance to the pathobiology of colon cancer , 2000, Pathology international.

[22]  W. Zimmermann,et al.  Carcinoembryonic antigen family members CEACAM6 and CEACAM7 are differentially expressed in normal tissues and oppositely deregulated in hyperplastic colorectal polyps and early adenomas. , 2000, The American journal of pathology.

[23]  S. Kitano,et al.  G-protein γ 7 is down-regulated in cancers and associated with P 27kip1-induced growth arrest , 1999 .

[24]  S. Kitano,et al.  G-protein gamma 7 is down-regulated in cancers and associated with p 27kip1-induced growth arrest. , 1999, Cancer research.

[25]  John Calvin Reed,et al.  Prolonged cell survival enhances peritoneal dissemination of gastric cancer cells , 1998, Oncogene.

[26]  Y. Kodera,et al.  Expression of carcinoembryonic antigen (CEA) and nonspecific crossreacting antigen (NCA) in gastrointestinal cancer; the correlation with degree of differentiation. , 1993, British Journal of Cancer.

[27]  K. Isobe,et al.  Nonspecific crossreacting antigen (NCA) is a major member of the carcinoembryonic antigen (CEA)-related gene family expressed in lung cancer. , 1993, British Journal of Cancer.

[28]  F. Grunert,et al.  Carcinoembryonic antigen gene family: Molecular biology and clinical perspectives , 1991, Journal of clinical laboratory analysis.

[29]  I. Forgacs.  GASTROENTEROLOGY , 1988, The Lancet.

[30]  Y Iwamoto,et al.  A rapid in vitro assay for quantitating the invasive potential of tumor cells. , 1987, Cancer research.